Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.240
+0.340 (17.89%)
At close: Apr 1, 2025, 4:00 PM
2.296
+0.056 (2.49%)
Pre-market: Apr 2, 2025, 6:18 AM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2018 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2019
Market Capitalization
310200199633309-
Upgrade
Market Cap Growth
0.34%0.34%-68.61%105.02%--
Upgrade
Enterprise Value
1907137516292-
Upgrade
Last Close Price
2.241.451.565.033.17-
Upgrade
PS Ratio
364.42234.71----
Upgrade
PB Ratio
2.471.591.343.492.21-
Upgrade
P/TBV Ratio
1.591.591.343.492.21-
Upgrade
EV/Sales Ratio
223.1483.51----
Upgrade
Debt / Equity Ratio
0.050.050.010.020.030.23
Upgrade
Asset Turnover
0.010.01----
Upgrade
Quick Ratio
14.2814.2819.5411.5413.594.66
Upgrade
Current Ratio
14.9614.9619.7312.0513.844.97
Upgrade
Return on Equity (ROE)
-36.07%-36.07%-25.74%-24.39%-91.30%-115.21%
Upgrade
Return on Assets (ROA)
-23.81%-23.81%-17.66%-14.73%-19.00%-42.25%
Upgrade
Return on Capital (ROIC)
-25.09%-25.09%-18.80%-15.84%-20.21%-45.80%
Upgrade
Earnings Yield
-15.94%-24.75%-21.37%-6.19%-26.60%-
Upgrade
FCF Yield
-14.50%-22.50%-20.44%-5.42%-6.98%-
Upgrade
Buyback Yield / Dilution
-8.15%-8.15%-20.76%-67.31%-104.28%-359.96%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q